Compare BIO-TECHNE Corp (TECH) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Western Union Co — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.36B), while Western Union Co trades at $6.32 (market cap $1.91B). The key difference: BIO-TECHNE Corp is far larger — about 5.9× Western Union Co's market cap, and Western Union Co pays the higher dividend (15.38%). Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Western Union Co for 95 Days on average.
| TECH | WU | |
|---|---|---|
Market Cap | $11.36B | $1.91B |
Volume | 5,390,331 | 6,459,194 |
Sector | Health | Financials |
52-Week High | $72.61 | $10.28 |
52-Week Low | $43.31 | $5.90 |
Typical Hold Time | 63 Days | 95 Days |
Enterprise Value | $11.39B | $1.81B |
Dividend Yield | 0.44% | 15.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $1.22B, with a net income margin of 14.97%. Valuation ratios are elevated, with a P/E of 62.46 and P/S of 9.36. A significant development is the shareholder-approved acquisition by Merck KGaA at $73.00 per share, pending completion.
The outlook is heavily influenced by the pending acquisition, offering a near-term price ceiling. Fundamentals show solid profitability but high valuation multiples. Risks include acquisition deal completion uncertainty and integration challenges. Analyst sentiment is mixed with no sell ratings, but the consensus price target of $65.78 suggests limited upside from current levels, making the stock a hold pending acquisition closure.
Western Union (WU) trades at $6.11, down 0.49% on the day, with bearish technical signals and mixed earnings performance. The stock shows attractive valuation metrics with a P/E of 4.93 and P/S of 0.48, while maintaining strong profitability with 9.79% net margins. Recent developments include the pending Intermex acquisition and expansion of retail partnerships, though earnings misses in Q1 and Q2 2026 raise execution concerns. Cash flow trends show volatility with a $469M net outflow in 2025.
WU presents a value opportunity with deep valuation discounts but faces execution risks amid digital transformation. The $200M cost-cutting plan and Intermex acquisition offer potential upside if successfully implemented, while competitive pressures and integration challenges pose downside risks. Analyst consensus at $6.86 suggests modest upside from current levels, though the mixed rating distribution reflects uncertainty about the turnaround strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
